News
In 2002, Dr. Foster structured a USD $215 million licensing deal, Canada’s largest at the time, for voclosporin for kidney transplant immunosuppression with Hoffman-La Roche.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback